PF-08046054 by Pfizer for Melanoma: Likelihood of Approval

Share this article While there is potential for correlation, there is not enough information to infer any causation, says Dr, Bruce Levine, professor at the

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

The Delaware Court of Chancery on Tues­day ruled in fa­vor of Ab­b­Vie, like­ly set­ting up the drug­mak­er to re­ceive most of the dam­ages it was